QUOTE AND NEWS
The Economic Times  Jul 25  Comment 
Approval has been granted for generic version of triamcinolone acetonide ointment USP, 0.5 per cent of Perrigo New York, Inc.
Benzinga  Jul 22  Comment 
  Deutsche Bank upgraded Perrigo Company plc (NYSE: PRGO) from Hold to Buy. Perrigo shares close at $91.52 on Thursday. Barclays upgraded Penn West Petroleum Ltd (USA) (NYSE: PWE) from Underweight to Equal-weight. Penn West Petroleum...
FiercePharma  Jul 18  Comment 
Shareholders sue struggling Perrigo for 'misleading' them away from Mylan buy chelfand Mon, 07/18/2016 - 11:48
Forbes  Jul 18  Comment 
Investors in Perrigo Company plc (NYSE: PRGO) saw new options become available today, for the September 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PRGO options chain for the new September 16th...
newratings.com  Jul 18  Comment 
NEW DELHI (dpa-AFX) - Perrigo Company plc (PRGO) said that the U.S. Food and Drug Administration has approved the company's ANDA for omeprazole and sodium bicarbonate capsules, 20mg/1100mg. This approval will initiate the first store brand...
Benzinga  Jul 18  Comment 
The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday July 15 through Sunday July 17, 2016:   Reckitt Benckiser Said to Bid for Perrigo The Rumor: Shares of Perrigo (NYSE: PRGO) spiked as high as...
Wall Street Journal  Jul 5  Comment 
Joseph Papa promised to start a “new chapter” at drugmaker Valeant, but Wall Street is questioning whether the man hired to bring about change can succeed after drawing from a similar playbook to Valeant’s at his previous company, Perrigo.
Benzinga  Jun 20  Comment 
Perrigo Company plc Ordinary Shares (NYSE: PRGO) shares have come under significant pressure after CEO Papa stepped down and the company reduced its guidance. Argus’ Jacob Kilstein downgraded the rating for Perrigo to Hold, citing the...
Reuters  Jun 20  Comment 
* Perrigo divests vitamins, minerals & supplements business to IVC Source text for Eikon: Further company coverage:
Benzinga  Jun 15  Comment 
Perrigo Company plc Ordinary Shares (NYSE: PRGO) shares are trading lower by $8.39 at $99.74 in Wednesday's session. It has nearly erased all of it gains since vague takeover rumors hit the tape on Tuesday afternoon. When contacted by Benzinga,...




 

Perrigo Company is a global health-care supplier and the world's largest manufacturer of over-the-counter pharmaceuticals for the store brand market. The company develops, distributes, and manufactures over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients, and consumer products.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki